Comparison of the Prognostic Value of the Child Pugh and MELD Scoring Systems in Cirrhosis -A Systematic Review

Authors

  • Marjan Assef CEO of the Marie Curie Science Research Center Author
  • Maneeth Mylavarapu MBBS, Graduate Student & Research Assistant Department of Public Health, Adelphi University, NY, USA Author
  • Patel Neel Kalpeshbhai MBBS, Fellow of Upasana Heart Hospital Author
  • Vu Thi Thu Hien Hanoi Medical University Author
  • Parakh Patel MD, American International Medical University Author
  • Puneet Kahlon MD, American International Medical University Author
  • Amna Minhas MBBS, Fatima Jinnah Medical University Author
  • Zain Ul Abdin CEO of the Marie Curie Science Research Center Author

DOI:

https://doi.org/10.47363/JCCEM/2022(1)115

Keywords:

Child Pugh Score, HBV, Liver Cirrhosis, Etiology

Abstract

This study provided an overview of the comparison of Child-Pugh scores for the assessment of prognosis in liver cirrhosis. We have reviewed all articles published from 1995-2022 comparing Child-Pugh score and MELD score for predicting prognosis in liver cirrhosis. In the majority of instances, Child-Pugh scores had similar prognostic relevance. However, given their distinct benefits for some specific disorders, additional research may be required to identify the candidates who should use the Child-Pugh score for prognosis assessment and the timing when we should use the Child-Pugh score for prognosis assessment. Although it was originally designed to predict mortality after surgery, the Child-Pugh score is today used to estimate prognosis, as well as the required strength of treatment and the need for liver transplantation. However, the Child-Pugh score is partly dependent on clinical examination, which may result in scoring differences. The Child-Pugh score does not take into account the etiology of cirrhosis, the possible combination of many causes, or the persistence of a destructive process such as persistent alcohol abuse or chronic hepatitis B infection (HBV). Even though its broad sickness classifications render it worthless in determining which patients should undergo a liver transplant first, it is nonetheless widely used.

Author Biographies

  • Marjan Assef, CEO of the Marie Curie Science Research Center

    Marjan Assefi, CEO of the Marie Curie Science Research Center.

  • Maneeth Mylavarapu, MBBS, Graduate Student & Research Assistant Department of Public Health, Adelphi University, NY, USA

    MBBS, Graduate Student & Research Assistant Department of Public Health, Adelphi University, NY, USA.

  • Patel Neel Kalpeshbhai, MBBS, Fellow of Upasana Heart Hospital

    MBBS, Fellow of Upasana Heart Hospital.

  • Vu Thi Thu Hien, Hanoi Medical University

    Hanoi Medical University.

  • Parakh Patel, MD, American International Medical University

    MD, American International Medical University.

  • Puneet Kahlon, MD, American International Medical University

    MD, American International Medical University.

  • Amna Minhas, MBBS, Fatima Jinnah Medical University

    MBBS, Fatima Jinnah Medical University.

  • Zain Ul Abdin, CEO of the Marie Curie Science Research Center

    CEO of the Marie Curie Science Research Center.

Downloads

Published

2025-12-04